HilleVax (HLVX) Competitors

HilleVax (NASDAQ:HLVX) and Olema Pharmaceuticals (NASDAQ:OLMA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership.

Which has preferable valuation and earnings, HLVX or OLMA?

Olema Pharmaceuticals is trading at a lower price-to-earnings ratio than HilleVax, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HilleVax	N/A	N/A	-$123.57M	-$3.00	-0.62
Olema Pharmaceuticals	N/A	N/A	-$96.65M	-$2.21	-2.30

Do analysts rate HLVX or OLMA?

HilleVax presently has a consensus target price of $3.00, suggesting a potential upside of 61.73%. Olema Pharmaceuticals has a consensus target price of $27.67, suggesting a potential upside of 445.48%. Given Olema Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Olema Pharmaceuticals is more favorable than HilleVax.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HilleVax	0 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Olema Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community prefer HLVX or OLMA?

Olema Pharmaceuticals received 27 more outperform votes than HilleVax when rated by MarketBeat users. Likewise, 71.15% of users gave Olema Pharmaceuticals an outperform vote while only 55.56% of users gave HilleVax an outperform vote.

Company	Underperform	Outperform
HilleVax	Outperform Votes 10 55.56%	Underperform Votes 8 44.44%
Olema Pharmaceuticals	Outperform Votes 37 71.15%	Underperform Votes 15 28.85%

Which has more volatility and risk, HLVX or OLMA?

HilleVax has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Comparatively, Olema Pharmaceuticals has a beta of 2.1, meaning that its stock price is 110% more volatile than the S&P 500.

Does the media prefer HLVX or OLMA?

In the previous week, Olema Pharmaceuticals had 3 more articles in the media than HilleVax. MarketBeat recorded 6 mentions for Olema Pharmaceuticals and 3 mentions for HilleVax. HilleVax's average media sentiment score of 1.22 beat Olema Pharmaceuticals' score of 0.87 indicating that HilleVax is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HilleVax	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Olema Pharmaceuticals	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is HLVX or OLMA more profitable?

Olema Pharmaceuticals' return on equity of -53.56% beat HilleVax's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HilleVax	N/A	-67.27%	-51.99%
Olema Pharmaceuticals	N/A	-53.56%	-47.86%

Do insiders & institutionals believe in HLVX or OLMA?

86.4% of HilleVax shares are held by institutional investors. Comparatively, 91.8% of Olema Pharmaceuticals shares are held by institutional investors. 71.1% of HilleVax shares are held by insiders. Comparatively, 19.4% of Olema Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Olema Pharmaceuticals beats HilleVax on 12 of the 15 factors compared between the two stocks.